Optimisation of pharmacotherapy in psychiatry through therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests: focus on antipsychotics.

Hart, X M, Gründer, G, Ansermot, N, Conca, A, Corruble, E, Crettol, S, Cumming, Paul, Hefner, G, Frajerman, A, Howes, O, Jukic, M, Kim, E, Kim, S, Manisalco, I, Moriguchi, S, Müller, D J, Nakajima, S, Osugo, M, Paulzen, M, Ruhe, H G, Scherf-Clavel, M, Schoretsanitis, G, Serretti, A, Spina, E, Spigset, O, Steimer, W, Süzen, H S, Uchida, H, Unterecker, S, Vandenberghe, F, Verstuyft, C, Zernig, G, Hiemke, C, Eap, C B

Open source

DOI
10.48350/198086
Published
2024
Container
Not recorded
Publisher
University of Bern
Open access
no

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.48350/198086,
  title = {Optimisation of pharmacotherapy in psychiatry through therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests: focus on antipsychotics.},
  author = {Hart, X M and Gründer, G and Ansermot, N and Conca, A and Corruble, E and Crettol, S and Cumming, Paul and Hefner, G and Frajerman, A and Howes, O and Jukic, M and Kim, E and Kim, S and Manisalco, I and Moriguchi, S and Müller, D J and Nakajima, S and Osugo, M and Paulzen, M and Ruhe, H G and Scherf-Clavel, M and Schoretsanitis, G and Serretti, A and Spina, E and Spigset, O and Steimer, W and Süzen, H S and Uchida, H and Unterecker, S and Vandenberghe, F and Verstuyft, C and Zernig, G and Hiemke, C and Eap, C B},
  year = {2024},
  doi = {10.48350/198086},
  url = {https://doi.org/10.48350/198086}
}

RIS

TY  - JOUR
TI  - Optimisation of pharmacotherapy in psychiatry through therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests: focus on antipsychotics.
AU  - Hart, X M
AU  - Gründer, G
AU  - Ansermot, N
AU  - Conca, A
AU  - Corruble, E
AU  - Crettol, S
AU  - Cumming, Paul
AU  - Hefner, G
AU  - Frajerman, A
AU  - Howes, O
AU  - Jukic, M
AU  - Kim, E
AU  - Kim, S
AU  - Manisalco, I
AU  - Moriguchi, S
AU  - Müller, D J
AU  - Nakajima, S
AU  - Osugo, M
AU  - Paulzen, M
AU  - Ruhe, H G
AU  - Scherf-Clavel, M
AU  - Schoretsanitis, G
AU  - Serretti, A
AU  - Spina, E
AU  - Spigset, O
AU  - Steimer, W
AU  - Süzen, H S
AU  - Uchida, H
AU  - Unterecker, S
AU  - Vandenberghe, F
AU  - Verstuyft, C
AU  - Zernig, G
AU  - Hiemke, C
AU  - Eap, C B
PY  - 2024
DO  - 10.48350/198086
UR  - https://doi.org/10.48350/198086
ER  - 

APA

M, H. X., G, G., N, A., A, C., E, C., S, C., Paul, C., G, H., A, F., O, H., M, J., E, K., S, K., I, M., S, M., J, M. D., S, N., M, O., M, P., G, R. H., M, S., G, S., A, S., E, S., O, S., W, S., S, S. H., H, U., S, U., F, V., C, V., G, Z., C, H., & B, E. C. (2024). Optimisation of pharmacotherapy in psychiatry through therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests: focus on antipsychotics.. https://doi.org/10.48350/198086

Source records